readthroughSign in
CompanyARVNNasdaqNew Haven, CT

Arvinas Inc.

Arvinas develops PROTAC protein degrader therapies targeting disease-causing proteins.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 3Latest story